Loading
Latest filing published 15 Jun 2026 for Ultragenyx Pharmaceutical Inc., €80k.
No signal scores available.
One trade, one date: on 15 June 2026, Karah Parschauer disclosed a transaction of €80k in Ultragenyx Pharmaceutical Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration